Dr. Alexey Stepanov is an Institute Investigator in the Department of Integrative Structural and Computational Biology at Scripps Research in La Jolla, California. He earned his PhD in 2013 from the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, and holds an MSc in Biology from Moscow State University.

Dr. Stepanov's research focuses on developing advanced anticancer therapies, particularly enhancing chimeric antigen receptor (CAR) T cell treatments for solid tumors. His work includes strategies to improve the specificity and safety of CAR T cells, such as using switchable adapters and targeting tumor-induced immunosuppressive mechanisms.